#SNF472 - Twitter Hashtag

over 3 years ago

The #CALCIPHYXstudy shows promising results for SNF472 in the treatment of #calciphylaxis. This randomized, double-blind, placebo-controlled #Phase3 trial demonstrates the potential of #SNF472 in improving patient outcomes. Explore more: https://t.co/wYbf7VE5fl #clinicaltrial

0

3

0

301

American Society of Pediatric Nephrology @ASPNeph

about 5 years ago

The #CALCIPHYX Study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of #SNF472 for the treatment of calciphylaxis @CKJsocial #RCT #openaccess https://t.co/roMN8yGo5N

ASPNeph's tweet photo. The #CALCIPHYX Study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of #SNF472 for the treatment of calciphylaxis @CKJsocial #RCT #openaccess
https://t.co/roMN8yGo5N https://t.co/1Qjly84ze3

2

4

2

0

Tras el Matraz @TrasElMatraz

about 5 years ago

L'altre dia vàrem presentar al congrés de l'@ERAEDTA uns resultats ben xulos de l'eficàcia del #SNF472 (en desenvolupment clínic per @SanifitLabs) en un model animal de malaltia arterial perifèrica. Aquí teniu un fil-resum de la presentació! ⬇⬇⬇

ERA - European Renal Association

@ERAkidney

about 5 years ago

🫀Dialysis: Heart & Vessels session summary 💢SNF472 ATTENUATES THE PROGRESSION OF FEMORAL ARTERY CALCIFICATION AND RECOVERS LIMB BLOOD PERFUSION AND WALKING ABILITY IN A RAT MODEL OF PERIPHERAL ARTERY DISEASE by Dr. Firas Bassissi #ERAEDTA21 #Calcification

ERAkidney's tweet photo. 🫀Dialysis: Heart & Vessels session summary
💢SNF472 ATTENUATES THE PROGRESSION OF FEMORAL ARTERY CALCIFICATION AND RECOVERS LIMB BLOOD PERFUSION AND WALKING ABILITY IN A RAT MODEL OF PERIPHERAL ARTERY DISEASE by Dr. Firas Bassissi
#ERAEDTA21 #Calcification https://t.co/gUTAEqtDOp

1

5

2

0

2

0

American Society of Pediatric Nephrology @ASPNeph

over 5 years ago

Effects of Myo-inositol Hexaphosphate (#SNF472) on Bone Mineral Density in Patients Receiving #Hemodialysis. An Analysis of the Randomized, Placebo-Controlled #CaLIPSO Study. @CJASN https://t.co/coYbwbSsZ1

ASPNeph's tweet photo. Effects of Myo-inositol Hexaphosphate (#SNF472) on Bone Mineral Density in Patients Receiving #Hemodialysis. An Analysis of the Randomized, Placebo-Controlled #CaLIPSO Study. @CJASN
https://t.co/coYbwbSsZ1 https://t.co/BQPTEgb1Gu

0

2

0

Universitat de les Illes Balears - UIB @UIBuniversitat

over 6 years ago

Una molècula patentada a la UIB inicia la fase 3 per convertir-se en medicament contra la calcifilaxi de la mà de @SanifitLabs! 👏S'ha administrat amb èxit el compost #SNF472 al primer pacient.👏 #SomUIB 👉 https://t.co/sanDDT2osl

0

10

1

0

Joan Perelló Bestard @perellojoan

over 6 years ago

#SNF472, first molecule that emerged from a Spanish university that reaches phase 3. Very proud of the Sanifit team!! @SanifitLabs @UIBuniversitat

7

43

18

0

Joan Perelló Bestard @perellojoan

over 6 years ago

Topline phase 2b CaLIPSO data presented at #AHA2019 by Paolo Raggi. Significant reduction in cardiovascular calcification progression with #SNF472!! @SanifitLabs

perellojoan's tweet photo. Topline phase 2b CaLIPSO data presented at #AHA2019 by Paolo Raggi. Significant reduction in cardiovascular calcification progression with #SNF472!! @SanifitLabs https://t.co/dNQRlAaISp

0

8

2

0

Smeeta Sinha @SmeetaSinha

over 6 years ago

SNF472, a novel inhibitor of calcification, attenuated CAC and aortic valve calcification over 52 weeks in patients on haemodialysis @CircAHA Patients @SRFTRenal and @MFTRenal supported the study as did 5 other UK sites #hurrahforapositivetrial #snf472 https://t.co/BytkotpgVa

1

23

12

0